Abstract
Neural avalanches, characterized by bursts of activity followed by periods of quiescence, have been observed in the brain and are thought to reflect the critical dynamics necessary for optimal information processing. Deviations from normal avalanche behavior have been hypothesized to underlie various neurological disorders, particularly schizophrenia. Schizophrenia is a complex psychiatric disorder associated with altered perception, cognition, and behavior, and recent theories suggest that disruptions in the brain’s critical dynamics may contribute to its pathophysiology. In this study, we present a computational model to investigate the properties of normal and imbalanced neural avalanches, with a focus on understanding the potential role of criticality in schizophrenia. We generate avalanche sizes using the Pareto distribution with a power law exponent of -3/2, which is consistent with experimental observations. The model incorporates increasing avalanche sizes over time to simulate the growth of neural activity. We introduce imbalance by adding lateness or earliness to the avalanche sizes, mimicking the potential disruptions in critical dynamics that may occur in schizophrenia. The mean and standard deviation of avalanche sizes are calculated to characterize the normal and imbalanced behavior. The results are visualized using line plots, with shaded areas representing the standard deviation range. Our model provides a framework for understanding the differences between normal and imbalanced neural avalanches, offering insights into the potential mechanisms underlying the altered critical dynamics in schizophrenia. By exploring the relationship between neural avalanches and schizophrenia, this study contributes to the ongoing efforts to elucidate the neurobiological basis of this disorder and may inform future research on potential diagnostic markers and therapeutic interventions targeting the brain’s critical dynamics.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Books
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Department of Mathematics
